Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-06-29

FDA Approved: TRANYLCYPROMINE SULFATE — Original Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a generic version of tranylcypromine sulfate for major depressive disorder under ANDA 040640, with Strides Pharma Science Limited as the applicant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tranylcypromine sulfate (Tranylcypromine sulfate)

Snippet

ORIG AP for TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE)